Hak-Hyun Nam
Founder bei I-SENS, INC.
Vermögen: 31 Mio $ am 31.03.2024
Profil
Hak-Hyun Nam is the founder of i-SENS, Inc. which was founded in 2000.
She is currently a Non-Executive Director at Precision Biosensor, Inc., a Director at I Sense Jiangsu Co., Ltd., and a Director at CoaguSense, Inc. Dr. Nam holds a doctorate degree from Michigan State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
I-SENS, INC.
7,21% | 15.04.2024 | 1 985 000 ( 7,21% ) | 30 Mio $ | 31.03.2024 |
| 30.06.2023 | 100 000 ( 0,86% ) | 362 488 $ | 31.03.2024 |
Aktive Positionen von Hak-Hyun Nam
| Unternehmen | Position | Beginn |
|---|---|---|
| I-SENS, INC. | Founder | 04.05.2000 |
| PRECISION BIOSENSOR, INC. | Director/Board Member | - |
| I Sense Jiangsu Co., Ltd. | Director/Board Member | - |
CoaguSense, Inc.
 CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Director/Board Member | - |
Ausbildung von Hak-Hyun Nam
| Michigan State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| I-SENS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Precision Biosensor, Inc. | |
| I Sense Jiangsu Co., Ltd. | |
CoaguSense, Inc.
CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Electronic Technology |
